3. The definition of hypertension and target BP goals The definition of hypertension in children is summarized in Table 16. The BP levels for children with CKD by age and height are shown in Table 17. For children with CKD, the National High Blood Pressure Education Program (NHBPEP) has recommended
a reduction in BP to below the 90th percentile based upon the age, gender, and height of the patient (Table 17). BP in children with CKD should be more strictly controlled based on the findings of the ESCAPE Trial and the fact that hypertension is a risk factor for the progression of CKD and CVD. Correct measurement of BP in children requires the use of a cuff that is appropriate to the size of the child’s upper right arm. Table 16 The definition of hypertension in children with CKD Bioactive Compound Library nmr Normal BP SBP and DBP that are <90th percentile for gender, age, and height Prehypertension Average SBP or DBP levels that are ≥90th percentile, but <95th percentile for gender, age, and height Average SBP or DBP levels that are ≥120/80 mmHg, but <95th percentile for gender, age, and height SN-38 Hypertension
Average SBP and/or DBP that is ≥95th percentile for gender, age, and height on at least 3 separate occasions Table 17 BP levels for boys and girls by age in the 50th percentile height Age, years Boys SBP/DBP, mmHg Girls SBP/DBP, mmHg 90th 95th 99th 90th 95th 99th 1 99/52 103/56 110/64 100/54 104/58 111/65 2 102/57 106/61 113/69 101/59 105/63 112/70 3 105/61 109/65 116/73 103/63 107/67 114/74 4 107/65 111/69 118/77 104/66 108/70 115/77 5 108/68 112/72 120/80 106/68 110/72 117/79 6 110/70 114/74 121/82 108/70 111/74 119/81 7 111/72 115/76 122/84 109/71 113/75 120/82 8 112/73 116/78 123/86 111/72 115/76 122/83 9 114/75 118/79 125/87 113/73 117/77 124/84 10 115/75 119/80 127/88 115/74 119/78 126/86 11 117/76 121/80 129/88 117/75 121/79 128/87 12 120/76 123/81 131/89 119/76 123/80 130/88 13 122/77 126/81 133/89 121/77 124/81 132/89 14 125/78 128/82 136/90 122/78
Methamphetamine 126/82 133/90 15 127/79 131/83 138/91 123/79 127/83 134/91 16 130/80 134/84 141/92 124/80 128/84 135/91 17 132/82 136/87 143/94 125/80 129/84 136/91 Falkner B, et al. Pediatrics. 2004;114:555–76 Bibliography 1. ESCAPE Trial Group, et al. N Engl J Med. 2009;361:1639–50. (Level 2) 2. Soergel M, et al. Pediatr Nephrol. 2000;15:113–8. (Level 4) 3. White CT, et al. Pediatr Nephrol. 2003;18:1038–48. (Level 3) 4. Rigosertib solubility dmso Franscini LM, et al. Am J Hypertens. 2002;15:1057–63. (Level 4) 5. von Vigier RO, et al. Eur J Pediatr. 2000;159:590–3. (Level 4) 6. Ellis D, et al. J Pediatr. 2003;143:89–97. (Level 4) 7. Ellis D, et al. Am J Hypertens. 2004;17:928–35. (Level 4) 8. Simonetti GD, et al. Pediatr Nephrol.